Fig. 3
From: Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
Asthma control by GINA assessment. Each time of measurement shows the number of patients with available information (the total n = 143). The percentage of uncontrolled patients fell considerably after omalizumab treatment starting (t − 0) with approximately 46% less patients being classified as uncontrolled at t − 1. The percentage of well controlled patients increased from 8 to 44% at t − 2